Skip to content

to compare the efficiency of some herbal drugs in the treatment of amavata

Comparative Study of Efficacy of â??Shiva Gugguluâ?? and â??Alambushadi Ghan Vatiâ?? in the Management of Amavata with special reference to Rheumatoid Arthritis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010844
Enrollment
50
Registered
2017-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- amavata ( rheumatoid arthritis)

Interventions

Intervention1: shiva guggulu: 2 Tab (each Tab 500mg.) three times in a day with lukewarm water, after meal for 30 days Control Intervention1: Alambushadi ghan vati: 2 Tab (each Tab 500 mg), three time

Sponsors

National Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients between the age group of 16 to 60 years in either sex presenting with clinical features of Amavata (R.A.). 2. Pre-diagnosed patient of Amavata. (Chronicity 3. Patient willing to sign the consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients having severe crippling bone deformities. 2. Patients suffering from paralysis. 3. Patients having any type of arthopathy such as neoplasm of spine, Gout, Ankylosing spondylosis, traumatic arthritis and pyogenic Osteomylitis etc. 4. Patients having associated Cardiac disease, Tuberculosis, Diabetes Mellitus, Malignant Hypertension, Renal Function Impairment; Hypothyroidism, RHD etc. 5. Patients with extremely reduced joint space. 6. Pregnant women and lactating mother.

Design outcomes

Primary

MeasureTime frame
Patients of either sex 16-60 yr old diagnosed with amavata (rheumatoid arthritis) will be selected for relief in sign and symptomsTimepoint: 30 days

Secondary

MeasureTime frame
Assess comparative efficacy of shiva gutika and alambushadi ghan vati in amavata (rheumatoid arthritis)Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Kumari Priya

National Institute of Ayurveda

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026